Dabigatran Etexilate Capsules 150 Mg

Pradaxa 150 mg

Description: Pradaxa 150 mg is an oral anticoagulant medication used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation (AFib). It contains Dabigatran Etexilate, a direct thrombin inhibitor that prevents the formation of blood clots by inhibiting thrombin, an enzyme essential for clotting.

Salt Composition:

• Dabigatran Etexilate (150 mg): A direct thrombin inhibitor that helps prevent blood clot formation by targeting thrombin.

Key Features:

• Direct Thrombin Inhibitor: Specifically inhibits thrombin to reduce the risk of clot formation.
• Oral Administration: Taken as a daily oral tablet, simplifying long-term management.
• Consistent Dosing: Provides predictable anticoagulation effects without the need for routine monitoring of blood levels.

Benefits:

• Reduces Stroke Risk: Helps lower the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
• Prevents Blood Clots: Effective in preventing deep vein thrombosis (DVT) and pulmonary embolism (PE).
• Convenient Use: Oral formulation allows for easy adherence to the prescribed regimen.

American Brand Names:

• Pradaxa

Indian Brand Names:

• Pradaxa 150 mg
• Dabigatran Etexilate Tablets (Various local brands)

Related Keywords: Pradaxa 150 mg, Dabigatran Etexilate, anticoagulant medication, stroke prevention, non-valvular atrial fibrillation treatment, oral blood thinner, American and Indian anticoagulant brands.